Workflow
透云生物(01332) - 2022 - 中期财报
TOUYUN BIOTECHTOUYUN BIOTECH(HK:01332)2022-09-21 09:40

Financial Performance - For the six months ended June 30, 2022, the company reported a loss attributable to shareholders of HKD 88.1 million, an increase of 43.5% compared to a loss of HKD 61.4 million for the same period in 2021[9]. - Revenue for the same period was approximately HKD 166.3 million, representing a 21.6% increase from HKD 136.8 million in the prior year[9]. - The overall gross margin decreased to 35.1% from 39.1% in the previous year[9]. - The company reported a net loss of approximately HKD 88,258,000 for the six months ended June 30, 2022, compared to a loss of HKD 72,074,000 in the same period of 2021, representing an increase in loss of about 22.5%[117]. - The gross profit for the period was HKD 58,338,000, compared to HKD 54,417,000 in the previous year, indicating a gross margin improvement[117]. - The company reported a pre-tax loss of HKD 65,014,000 for the six months ended June 30, 2022, compared to HKD 58,294,000 in the same period of 2021[179]. - The total employee benefits expenses, including directors' remuneration, amounted to HKD 65,014,000 in 2022, compared to HKD 58,294,000 in 2021, reflecting an increase of approximately 11.5%[179]. Segment Performance - The QR code business generated revenue of HKD 38.2 million, a decrease of 33.2% compared to HKD 57.2 million in the same period last year, resulting in a segment loss of HKD 4.6 million[10]. - The packaging products business recorded revenue of HKD 123.8 million, a significant increase of 51.2% from HKD 81.9 million in the prior year, with a segment profit of HKD 13.1 million[14]. - Revenue from the production and sale of packaging products reached HKD 123,792,000 in 2022, up from HKD 81,885,000 in 2021, indicating a significant increase of about 51%[166]. - The revenue from QR code packaging products and solutions was HKD 38,249,000, down from HKD 57,221,000 in 2021, reflecting a decrease of approximately 33.1%[171]. Financial Position - The company held cash reserves of approximately HKD 35 million as of June 30, 2022, down from HKD 60.2 million at the end of 2021[17]. - The debt-to-equity ratio increased to approximately 0.99 from 0.67 at the end of 2021[17]. - The company's current liabilities exceeded current assets by approximately HKD 283,458,000 as of June 30, 2022[107]. - The company's net asset value decreased to HKD 401,968 thousand as of June 30, 2022, down from HKD 487,045 thousand as of December 31, 2021, a decline of about 17.4%[123]. - The total equity attributable to the owners of the company was HKD 385,032 thousand as of June 30, 2022, down from HKD 469,917 thousand as of December 31, 2021, a decrease of approximately 17.9%[123]. - The company’s total current liabilities increased to HKD 294,109 thousand as of June 30, 2022, compared to HKD 268,217 thousand as of December 31, 2021, an increase of approximately 9.7%[122]. Cash Flow and Financing - The company's net cash flow from operating activities for the six months ended June 30, 2022, was a negative HKD 62,056 thousand, compared to a negative HKD 151,523 thousand for the same period in 2021, indicating an improvement[131]. - The company’s cash flow from investing activities showed a net outflow of HKD 114,420 thousand for the six months ended June 30, 2022[131]. - The company raised net new borrowings of HKD 44,646 thousand during the financing activities for the six months ended June 30, 2022[131]. - The company is actively negotiating loan restructuring with existing lenders to extend repayment schedules and alleviate financial constraints[111]. - Financial institutions have expressed willingness to provide new loans to the company for operational funding[137]. Shareholder Information - As of June 30, 2022, the company has a total of 624,000,000 shares held by Mr. Wang Liang, representing approximately 27.58% of the total issued shares[38]. - The company’s shareholding structure includes significant holdings by major shareholders, with Mr. Wang Liang holding 22.24% and Ms. Qiao Yan Feng holding 5.35%[45]. - The company did not recommend any interim dividend for the six months ended June 30, 2022[31]. - The weighted average number of ordinary shares used to calculate basic and diluted loss per share was 2,805,952,000 for the six months ended June 30, 2022, compared to 2,785,759,000 for the same period in 2021[187]. Investments and Acquisitions - A total of HKD 142,700,000 is allocated for expanding and developing its QR code business, with RMB 55,000,000 (approximately HKD 63,000,000) used for acquiring a subsidiary in China[57]. - The company has completed the acquisition of Tongyun Internet Technology (Beijing) Co., Ltd. in March 2017, with HKD 63,000,000 fully utilized for this acquisition[57]. - The company plans to maintain a flexible investment portfolio to withstand potential market volatility in the second half of 2022[99]. Corporate Governance - The company has committed to adhering to corporate governance codes throughout the six months ending June 30, 2022, with one non-executive director absent from the annual general meeting[100]. - There were no significant investments, acquisitions, or disposals during the reporting period[29].